Closed |
SWOG-9462 (NABTC-9404) (NCI T94-0034) |
A Phase I Trial and Pharmacokinetic Study of the Sequential Administration of Carmustine (BCNU) and Temozolomide in Patients with CNS or Systemic Tumors Refractory to Standard Therapy |
7/28/1995 |
8/15/1997 |
90% |
|
|
Closed |
SWOG-9128 |
Phase I Trial of Doxorubicin, DTIC and Ifosfamide with Recombinant Granulocyte-Macrophage Colony Stimulating Factor/Peripheral Blood Progenitor Cell Infusion in Advanced Soft Tissue Sarcomas |
9/1/1992 |
12/1/1994 |
47% |
|
|
Closed |
SWOG-9026 |
A Phase I, Open Label, Multicenter Study of the Safety, Tolerability and Biological Effects of SDZ ILE 964 (Recombinant Human Interleukin-3), Administered to Patients with Metastatic Cancer Prior to… |
7/15/1991 |
9/29/1992 |
100% |
|
Published
|
Closed |
S0004 |
Tirapazamine/Cis/Etopo/RT in Limited SCLC |
10/15/2000 |
4/1/2002 |
60% |
|
Published
|
Closed |
S0355 |
Phase I Pharmacokinetic Study |
11/1/2003 |
8/15/2006 |
100% |
|
Published
|
Closed |
S0429 |
Docetaxel and Cetuximab Chemoradiation in Stage III NSCLC |
4/1/2006 |
8/15/2009 |
40% |
|
Published
|
Closed |
S0528 |
Phase I Study of Lapatinib and Everolimus in Advanced Solid Tumors |
9/1/2006 |
8/25/2009 |
100% |
|
Published
|
Closed |
S0711 |
Dasatinib in patients with impaired hepatic function |
10/15/2008 |
|
100% |
|
|
Closed |
S1312 |
PI/II Inotuzumab + CVP for R/R CD22+ ALL |
4/1/2014 |
8/2/2019 |
100% |
|
|
Closed |
SWOG-8367 |
Combined Modality Treatment of Regional Non-Small Lung Cancer |
12/1/1983 |
10/1/1986 |
|
|
Published
|
Closed |
SWOG-8944 |
A Study of Carboplatin (CBDCA) in Refractory Multiple Myeloma |
3/1/1990 |
6/1/1991 |
48% |
|
Published
|
Closed |
SWOG-8378 |
Evaluation of Fludarabine Phosphate in Chronic Lympho- cytic Leukemia |
12/5/1983 |
6/15/1987 |
|
|
|
Closed |
SWOG-9436 (NABTC-9403) (NCI T94-0184) |
A Phase I/II Trial of Paclitaxel (Taxol®) Chemotherapy for Recurrent Malignant Glioma |
4/18/1995 |
2/4/1998 |
95% |
|
Published
|
Closed |
SWOG-8518 |
Study of Combined Modality Treatment For Inoperable Squamous Cell Carcinoma of the Esophagus (Stage III By Moss Classification) |
10/15/1986 |
6/1/1988 |
|
|
|
Closed |
SWOG-717 |
Combination Drug (Cytoxan (NSC-26271), Vincristine (NSC-67574), Methotrexate (NSC-740) and 5-Fluorouracil (NSC-19893) Chemotherapy of Solid Tumor in Adults |
7/29/1968 |
|
4% |
|
|
Closed |
SWOG-8377 |
High Dose Cyclophosphamide, VP-16-213 and Cis-Platinum Followed by Autologous Bone Marrow Transplantation in the Treatment of Relapsing or Germ Cell Tumors |
6/11/1984 |
9/27/1985 |
|
|
|
Closed |
SWOG-8735 |
A Phase II Study of Recombinant Human Interferon- Alpha and Recombinant Human Interferon-Gamma in Previously Untreated Patients with Chronic Myelogenous Leukemia |
4/1/1988 |
5/15/1990 |
57% |
|
|
Closed |
S0114 |
EGFRvIII Peptide Vaccine |
11/1/2002 |
6/1/2006 |
47% |
|
|
Closed |
S0533 |
Cisplatin/Etoposide/RT/Docetaxel and Three Cohorts of Bevacizumab-Advanced Stage III NSCLC |
6/15/2006 |
3/1/2010 |
16% |
|
Published
|
Closed |
S0727 |
Pancreas Ph I/II gemcitabine, erlotinib, IMC-A12 |
3/1/2008 |
9/1/2010 |
100% |
|
Published
|